Jefferies Group LLC Aclaris Therapeutics, Inc. Transaction History

Jefferies Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$13.38 - $18.8 $536,042 - $753,184	-40,063 Closed	0 $0
Q2 2021 Sep 21, 2023	BUY	$17.08 - $29.6 $684,276 - $1.19 Million	40,063 New	40,063 $703,000
Q2 2021 Aug 16, 2021	BUY	$17.08 - $29.6 $684,276 - $1.19 Million	40,063 New	40,063 $704,000
Q2 2019 Aug 14, 2019	SELL	$2.13 - $7.06 $45,230 - $149,919	-21,235 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$5.63 - $7.84 $54,059 - $75,279	-9,602 Reduced 31.14%	21,235 $127,000
Q4 2018 Feb 14, 2019	BUY	$6.3 - $15.4 $88,641 - $216,678	14,070 Added 83.91%	30,837 $228,000
Q3 2018 Nov 14, 2018	BUY	$14.38 - $20.89 $241,109 - $350,262	16,767 New	16,767 $243,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $271M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.